Precision Prevention: The 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
The approach to cervical cancer prevention has evolved significantly over the past two decades. HPV immunization has decreased the specificity of screening modalities and HPV-based testing has been replacing our previously successful morphology-only approach. Additionally, there is much more emphasi...
Saved in:
Main Author: | Ritu Nayar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Different Guidelines for Cervical Cancer Screening and Management of Abnormal Cervical Cytology
by: M Samy Ismail, et al.
Published: (2020) -
Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
by: Luiz Carlos Zeferino, et al.
Published: (2018) -
Guidelines for cervical cancer screening in China
by: Mingzhu Li, et al.
Published: (2023) -
USERS' PERCEPTION OF SCREENING TESTS FOR PREVENTING CERVICAL CANCER
by: Karla Torres de Queiroz Neves, et al.
Published: (2016) -
Review of the Brazilian Guidelines for Cervical Cancer Screening, 2016
by: Leticia Maria C. Katz